Endogenous peptides contribute to the ligand recognized by anti-DR1 human alloreactive T cells
Lombardi, G.; Sidhu, S.; Lamb, J.R.; Batchelor, J.R.; Lechler, R.I.
Transplantation Proceedings 21(1 Pt 1): 142-144
1989
ISSN/ISBN: 0041-1345 PMID: 2495597 Document Number: 336245
Document emailed within 1 workday
Related Documents
Deng, Y.; Yewdell, J.W.; Eisenlohr, L.C.; Bennink, J.R. 1997: MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL Journal of Immunology 158(4): 1507-1515Horneland, M.; Rekvig, O.P.; Jørgensen, L.; Hannestad, K. 1983: Cultured human endothelial cells display an antigen that is recognized by certain human anti-chromatin autoantibodies Clinical and Experimental Immunology 54(2): 373-377
Goetzl, E.J.; Chernov-Rogan, T.; Cooke, M.P.; Renold, F.; Payan, D.G. 1985: Endogenous somatostatin-like peptides of rat basophilic leukemia cells Journal of Immunology 135(4): 2707-2712
Laine, R.O.; Esser, A.F. 1989: Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies Journal of Immunology 143(2): 553-557
Khanna, R.; Cooper, L.; Kienzle, N.; Moss, D.J.; Burrows, S.R.; Khanna, K.K. 1997: Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells Journal of Immunology 159(12): 5782-5785
Zhou, S.; Mao, N.; Zhao, M. 1998: Effect of recombinant human FLT3 ligand (rhFL) on in vitro expansion of human cord blood CD34+ cells Zhonghua Yi Xue Za Zhi 78(1): 37-39
Vidinský, B.; Gál, P.; Pilátová, M.; Vidová, Z.; Solár, P.; Varinská, L.; Ivanová, L.; Mojžíš, J. 2012: Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation Folia Biologica 58(2): 75-80
Ward, L.D.; Shi, P.T.; Simpson, R.J. 1992: Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance Biochemistry International 26(3): 559-565
Fukui, S.; Horie, T.; Numata, Y.; Kitagawa, H.; Nakada, H.; Kawasaki, T.; Funakoshi, I.; Yamashina, I. 1991: Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells Cancer Research 51(1): 331-335
Kabelitz, D.; Enssle, K.H.; Fleischer, B.; Reimann, J. 1987: Antigen-presenting T cells. II. Clonal responses of alloreactive and virus-specific self-restricted human cytotoxic T cell responses stimulated by T lymphoblasts Journal of Immunology 138(1): 45-50
Sun, W.; Jiang, Z.; Xiang, T.-X.; Tao, X.-H.; Huang, A.-L.; Wang, P.-L. 2009: Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice Zhonghua Yi Xue Za Zhi 89(12): 841-845
Choe, J.; Kim, H.S.; Zhang, X.; Armitage, R.J.; Choi, Y.S. 1996: Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis Journal of Immunology 157(3): 1006-1016
Pala, P.; Corradin, G.; Strachan, T.; Sodoyer, R.; Jordan, B.R.; Cerottini, J.C.; Maryanski, J.L. 1988: Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides Journal of Immunology 140(3): 871-877
Nevala, W.K.; Paul, C.; Wettstein, P.J. 1998: Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation Transplantation 65(4): 559-569
Charpentier, B.; Michelson, S.; Martin, B. 1986: Definition of human cytomegalovirus-specific target antigens recognized by cytotoxic T cells generated in vitro by using an autologous lymphocyte system Journal of Immunology 137(1): 330-336
Miyagawa, Y. 1984: Further characterization of IgM antibodies against maternal alloreactive T cells produced by cloned Epstein Barr virus-transformed cord B cells Journal of Immunology 133(3): 1270-1277
Kozaeva, L.P.; Korobov, N.V. 2003: Agmatine--an endogenous ligand of imidazoline receptors Eksperimental'naia i Klinicheskaia Farmakologiia 66(5): 69-73
Vernino, L.; McAnally, L.M.; Ramberg, J.; Lipsky, P.E. 1992: Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells Journal of Immunology 148(2): 404-410
Komai-Koma, M.; Liew, F.Y.; Wilkinson, P.C. 1995: Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells Journal of Immunology 155(3): 1110-1116
Gao, Y.-d.; Xiong, D.-s.; Yang, M.; Xu, Y.-f.; Shao, X.-f.; Peng, H.; Fan, D.-m.; Yang, C.-z. 2005: An anti-P-gp/anti-CD3 bispecific antibody cytotoxic to human multidrug resistant KB cells Zhonghua Zhong Liu Za Zhi 27(11): 653-656